Corrected Version: Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
Journal of Clinical & Experimental Immunology · 03.08.2026 · 11 (03) · 01-17
DOI: 10.33140/jcei.11.03.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical & Experimental Immunology, online erschienen am 03.08.2026. Verfasst von Goutam Chandra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Sciences, Rush University Medical Center, Chicago, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NINDS NIH HHS.
Abstract (Originalsprache)
Parkinson’s disease (PD) is second only to Alzheimer’s disease as the most common human neurodegenerative disorder. Despite intense investigation, no interdictive therapy is available for PD. Recent studies indicate that both innate and adaptive immune processes are active in PD. Accordingly, we found rapid increase in RANTES (regulated on activation, normal T cell expressed and secreted) and eotaxin, chemokines that are involved in T cell trafficking, in vivo in the substantia nigra pars compacta (SNpc) and the serum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- intoxicated mice. RANTES and eotaxin were also upregulated in the SNpc of postmortem PD brains as compared to age-matched controls. Therefore, we investigated whether neutralization of RANTES and eotaxin could protect against nigrostriatal degeneration in MPTP-intoxicated mice. Interestingly, after peripheral administration, functional blocking antibodies against RANTES and eotaxin reduced the infiltration of CD4+ and CD8+ T cells into the nigra, attenuated nigral expression of proinflammatory molecules, and suppressed nigral activation of glial cells. These findings paralleled dopaminergic neuronal protection, normalized striatal neurotransmitters, and improved motor functions in MPTPintoxicated mice. Therefore, we conclude that attenuation of chemokine-dependent adaptive immune response may be of therapeutic benefit for PD patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.
ORCID-Profile: Kalipada Pahan
Förderung
- BLRD VA
- NINDS NIH HHS
Zitieren
APA
Chandra, G., Rangasamy, S. B., & Pahan, K. (2026). Corrected Version: Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease. Journal of Clinical & Experimental Immunology, 11(03), 01-17. https://doi.org/10.33140/jcei.11.03.04
Vancouver
Chandra G, Rangasamy SB, Pahan K. Corrected Version: Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease. Journal of Clinical & Experimental Immunology. 2026;11(03):01-17. doi:10.33140/jcei.11.03.04
BibTeX
@article{Chandra2026,
author = {Chandra, Goutam and Rangasamy, Suresh B and Pahan, Kalipada},
title = {Corrected Version: Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease},
journal = {Journal of Clinical & Experimental Immunology},
year = {2026},
volume = {11},
number = {03},
pages = {01--17},
doi = {10.33140/jcei.11.03.04}
}
EUVIMED